Aortoiliac embolism presenting as acute limb ischaemia in infants and children under 2 years of age represents a distinct clinical situation. This age group requires a specific, age-adapted management strategy.
In this age group, initial management centres on conservative systemic anticoagulation. The complete protocol — including agent selection, age-specific parameters, and how monitoring targets are applied — is detailed in the full structured regimen.
Response is assessed through coagulation monitoring. Achieving and maintaining the target coagulation range is the primary measure of therapeutic success.
DOI: 10.1016/j.ejvs.2019.09.006
For infants and children younger than 2 years of age with acute limb ischaemia, initial conservative management with heparin is recommended.
Both UFH and LMWH may be used as anticoagulants.
View source ↗